a public good project by the
Synthesis
Company
of California

© 2026

Nadia Routabi | doi.page

0 works0 citations0 h-index

Google Scholar OpenAlex

Nadia Routabi

King's College London(GB)

Research Areas

Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Nanoplatforms for cancer theranostics

Most-Cited Works

→ Nanoparticle-Mediated In Situ Molecular Reprogramming of Immune Checkpoint Interactions for Cancer Immunotherapy(2021)41 cited